Introduction {#s0001}
============

Small mothers against decapentaplegic (*SMAD*) proteins are a family of transducers and transcriptional modulators that functions by transforming the growth factor beta (TGF-β) signaling pathway. Alterations of the TGF-β signal pathway lead to uncontrolled cell proliferation, thereby contributing to oncogenesis.[@cit0001] Ligands of the TGF-β family bind to complexes formed by its type I and type II receptors to trigger the pathway. The activated type I receptors then phosphorylate receptor-activated *SMAD*s (R-*SMAD*s, including *SMAD*2, −3, −5, −8) which then interact with *SMAD*4 (also known as the co-*SMAD*) to form a heterotrimeric complex that consists of two R-SMADs and one co-*SMAD*.[@cit0001],[@cit0002] A subgroup of inhibitory *SMAD*s (I-*SMAD*s, including *SMAD*6, −7) attenuates the signaling by competing with the R-SMADs for TGF-β receptors or directly interacting with R-SMADs.[@cit0001],[@cit0003],[@cit0004]

Drugs that mediate the TGF-β signaling pathway have shown increasing potency of changing the current treatment of various cancers.[@cit0005] Given that the *SMAD*s family play a key role in activation or inhibition of the TGF-β signaling pathway, further studies on SMADs are becoming essential and promising.[@cit0006] *SMAD3* has been proven to have diverse correlations with different types of malignant tumors. For example, *SMAD3* impairment is associated with dysregulated cell proliferation and apoptosis in ovarian granulosa cell tumors.[@cit0007] In human colorectal cancer, linker phosphorylation of *SMAD3* is associated with tumor metastasis.[@cit0008] Inhibition of *SMAD3* diminishes the invasion and metastatic ability of breast cancer.[@cit0009],[@cit0010] In addition, the expression of *SMAD3* suppressed tumor development in gastric cancer.[@cit0011] Similarly, *SMAD6* has been demonstrated to be related to poor prognosis in non-small cell lung cancer.[@cit0012],[@cit0013] However, there is only little evidence that shows *SMAD3* or *SMAD6* contribute to the progression of ESCC, especially the relationship between *SMAD* gene and ESCC. Cognizant to this, our study aimed to explore whether SNPs in SMAD3 or *SMAD6* had an effect on the risk of ESCC.

Patients and Methods {#s0002}
====================

Ethical Statement {#s0002-s2001}
-----------------

This was a case--control study approved by the Ethics Review Board of Jiangsu University (Zhenjiang, China). All study participants gave written informed consent prior to the study. The study also complied with the World Medical Association Declaration of Helsinki regarding ethical aspects of research involving human/animal subjects.

Study Population {#s0002-s2002}
----------------

A total of 2358 participants were enrolled in the study, of which 1043 were ESCC cases and 1315 non-cancer individuals acted as the controls. Frequency-matching of both groups was done based on gender and age. All participants were consecutively recruited from the Affiliated People's Hospital of Jiangsu University and Affiliated Hospital of Jiangsu University (Zhenjiang, China) between October 2008 and January 2017. All cases of ESCC were diagnosed histologically. Patients with a history of malignant tumor, metastasized cancer, and/or those who had undergone chemotherapy/radiotherapy were excluded from the study.

Individual interviews were conducted using a questionnaire well formulated to collect data of all the necessary demographic information and related risk factors. Then, participants gave 2 mL venous blood samples for subsequent tests. Participants who smoked at least one cigarette per day for the last one year or more were categorized as the "tobacco consumption" subgroup while those who drank more than three alcoholic drinks per week for the past six months or more were categorized as the "alcohol consumption" subgroup.

DNA Extraction and SNP Genotyping {#s0002-s2003}
---------------------------------

Genomic DNA was isolated from the collected venous blood samples using the QIAamp DNA Blood Mini Kit (Qiagen, Berlin, Germany) following the manufacturer's protocol.[@cit0014] The genotypes of 7 SNPs were then analyzed using the ligation detection reaction (LDR) method with technical support from Genesky Biotechnology Inc. (Shanghai, China). Quality control was done by repeating the analyses using 10% of randomly selected samples. Pilot linkage disequilibrium analyses were performed in the Chinese Han population to choose the SNP loci with moderate correlation, and tag SNPs were selected for further analyses.

Statistical Analysis {#s0002-s2004}
--------------------

All statistical analyses were conducted using the SPSS 25.0 statistical software package (SPCC Inc., Chicago, IL). Hardy--Weinberg equilibrium (HWE) for the genotypes was tested by goodness-of-fit *χ*^2^ in the control group. Variations in demographic characteristics and genotypes of the *SMAD3* rs8028147, rs3743343, rs3743342, rs8025774, rs8031440, rs8031627, and *SMAD6* rs34643453 between both groups were evaluated using the *χ*^2^ test to determine their statistical differences. The associations between these 7 SNPs and risk of ESCC were assessed by odds ratio (OR) and 95% confidence interval (CI) using logistics regression analyses for crude ORs and adjusted ORs according to age, sex, and tobacco and alcohol consumption status. Two-sided *P* value \<0.05 was considered as statistically significant.

Results {#s0003}
=======

Characteristics of the Study Population {#s0003-s2001}
---------------------------------------

The demographic information and risk factors of the participants are shown in [Table 1](#t0001){ref-type="table"}. Age and gender were well matched in cases and control groups. However, the smoking and alcohol drinking statuses were significantly different between the groups (*P*\<0.01).Table 1Distribution of Selected Demographic Variables and Risk Factors in ESCC Case and Control GroupsCase Group (n=1043)Control Group (n=1315)*P*Age (years) Mean ± SD63.07 ± 7.2762.88 ± 9.740.607Age (years) \<6347145.16%63648.37%0.121 \>6357254.84%67951.63%Gender Male75872.67%95272.40%0.88 Female28527.33%34326.08%Smoking status Never58956.47%96473.31%\<0.001 Ever45443.53%35126.69%Alcohol consumption Never71468.46%122292.93%\<0.001 Ever32931.54%937.07%

[Table 2](#t0002){ref-type="table"} provides primary information of the 7 genotyped SNPs. The success rates of SNP genotyping were variable and the rates ranged between 95% and 100%. The minor allele frequency (MAF) of SNPs in the control group corresponded with that of the Chinese Han population provided by HapMap. Deviation tests for the HWE revealed that the control population was in the Hardy--Weinberg proportions for all the 7 SNPs with a significance level of 0.05.Table 2Primary Information of the Selected SNPsGenotyped SNPrs8028147rs3743343rs3743342rs8025774rs8031440rs8031627rs34643453Ancestral AlleleGTCCGGGGene*SMAD3*(4088)*SMAD6*(4091)Functionutr variant 5 primeutr variant 3 primeutr variant 5 primeRegulome DB Score^a^453a4444TFBS^b^------------YnsSNP--------------Chr Pos67,125,89567,194,43767,193,32967,190,93867,191,64167,191,78166,702,737Chromosome15151515151515x\`MAF for Chinese in database(HAPMAP)G = 0.440C = 0.314T = 0.453T = 0.451A = 0.463A = 0.451A = 0.268MAF in the\
ControlsG=0.416C=0.317T=0.462T=0.456A=0.461A=0.455A=0.255*P* value for\
HWE test in the controls0.80660.16880.74320.77860.76410.85740.7750Genotyping methodLDR%Genotyping value99.02%99.02%99.02%99.02%98.98%99.02%95.59%[^2]

The Risk of ESCC Associated with SNPs {#s0003-s2002}
-------------------------------------

The association between the risk of ESCC and each SNP is presented in [Table 3](#t0003){ref-type="table"}. It presents the results obtained from the analysis of the association between the risk of ESCC and each SNP. The co-dominant model test, dominant model test, recessive model test, and an allelic test revealed that among the selected SNPs, *SMAD3* rs3743342 C\>T, rs8025774 C\>T, rs8031440 G\>A, and rs8031627 G\>A were closely associated with a higher risk of ESCC in the case groups (*P*\<0.05).Table 3Main Effects of Rs8028147 G\>A, Rs3743343 T\>C, Rs3743342 C\>T, Rs8025774 C\>T, Rs8031440 G\>A, Rs8031627 G\>A, Rs3463453 G\>A on Risk of ESCCLocusGenotypeControlCaseCo-DominantDominantRecessiveAllelic TestOR (95% CI)*P*OR (95% CI)/*P*OR (95% CI)/*P*OR (95% CI)/*P*rs8028147GG22516910.8541.050(0.844--1.307)\
0.6601.042(0.878--1.238)\
0.6361.034(0.920--1.163)\
0.576GA6414991.070 (0.839--1.365)0.583AA4443571.036(0.822--1.306)0.762rs3743343TT60049810.4070.894(0.759--1.053)\
0.1810.957(0.720--1.273)\
0.7650.929(0.820--1.053)\
0.249TC5894360.515(0.673--1.219)0.515CC121910.191(0.751--1.059)0.191rs3743342CC37724310.0011.300(1.078--1.568)\
0.0061.360(1.123--1.648)\
0.0021.237(1.102--1.389)\
\<0.001TC6575091.202(0.986--1.466)0.069TT2762731.535(1.216--1.936)\<0.001rs8025774CC38525310.0021.270(1.055--1.528)\
0.0111.371(1.130--1.662)\
0.0011.230(1.096--1.381)\
\<0.001TC6555031.169(0.960--1.423)0.120TT2702691.516(1.203--1.911)\<0.001rs8031440GG37725010.0021.254(1.041--1.510)\
0.0171.379(1.139--1.670)\
0.0011.228(1.094--1.379)\
0.001GA6564991.147(0.941--1.398)0.174AA2762761.508(1.197--1.900)\<0.001rs8031627GG38725210.0011.286(1.069--1.548)\
0.0081.384(1.142--1.679)\
0.0011.241(1.106--1.394)\
\<0.001GA6535021.181(0.970--1.437)0.098AA2702711.541(1.223--1.943)\<0.001rs3464453GG68157810.6870.954(0.807--1.127)\
0.5811.084(0.776--1.513)\
0.6370.983(0.859--1.124)\
0.798GA4713760.937(0.787--1.117)0.468AA78701.056(0.751--1.485)0.755

Stratification Analyses of *SMAD3* rs3743342 C\>T, rs8025774 C\>T, rs8031440 G\>A, rs8031627 G\>A and the Risk of ESCC {#s0003-s2003}
----------------------------------------------------------------------------------------------------------------------

Stratification analyses were conducted to further access *SMAD3* rs3743342 C\>T, rs8025774 C\>T, rs8031440 G\>A, and rs8031627 G\>A on the risk of ESCC in the different subgroups based on gender, age, and smoking and alcohol drinking status.

The results of stratification analyses share a remarkable similarity ([Tables 4](#t0004){ref-type="table"}[](#t0005){ref-type="table"}[](#t0006){ref-type="table"}--[7](#t0007){ref-type="table"}). In males, participants older than 63 years, smokers, and non-alcohol drinking participants, almost all the mutant homozygotes of these four SNPs (except rs8031440 G\>A in smokers) had a significantly higher likelihood of having ESCC (*P*\<0.05).Table 4Stratified Analyses Between Rs3743342 Polymorphism and ESCC Risk by Gender, Age, Smoking Status, and Alcohol ConsumptionVariablesControl/CaseAdjusted OR/*P*\
(95% CI of OR)CCTCTTTC+TTCCTCTTTC+TTTT vs (TC+CC)GenderMale283/169476/370189/206665/5761.001.235/0.105\
(0.957--1.592)1.838/\<0.001\
(1.366--2.474)1.404/0.006\
(1.105--1.784)0.624/\<0.001\
(0.489--0.797)Female94/74181/13987/67268/2061.000.967/0.863\
(0.661--1.414)0.970/0.892\
(0.622--1.513)0.968/0.858\
(0.677--1.384)1.009/0.962\
(0.697--1.460)Age\<63195/123298/231139/112437/3431.001.276/0.118\
(0.940--1.732)1.373/0.085\
(0.957--1.971)1.306/0.068\
(0.980--1.741)0.849/0.292\
(0.626--1.151)≥63182/120359/278137/161496/4391.001.049/0.751\
(0.783--1.405)1.655/0.004\
(1.179--2.323)1.215/0.167\
(0.922--1.602)0.624/0.001\
(0.474--0.822)Smoking StatusNever277/140473/282210/152683/4341.001.173/0.218\
(0.910--1.513)1.438/0.016\
(1.070--1.931)1.254/0.063\
(0.987--1.593)0.772/0.037\
(0.605--0.984)Ever100/103184/22766/121250/3481.001.067/0.735\
(0.731--1.559)1.731/0.018\
(1.100--2.275)1.237/0.244\
(0.865--1.771)0.603/0.009\
(0.414--0.879)Alcohol consumptionNever351/174608/339258/190866/5291.001.113/0.356\
(0.887--1.396)1.472/0.004\
(1.132--1.914)1.220/0.068\
(0.986--1.509)0.728/0.004\
(0.586--0.905)Ever26/6949/17018/8367/2531.001.279/0.397\
(0.723--2.264)1.723/0.126\
(0.859--3.456)1.400/0.224\
(0.814--2.410)0.687/0.205\
(0.385--1.228) Table 5Stratified Analyses Between Rs8025774 Polymorphism and ESCC Risk by Gender, Age, Smoking Status, and Alcohol ConsumptionVariablesControl/CaseAdjusted OR/*P*\
(95% CI of OR)CCTCTTTC+TTCCTCTTTC+TTTT vs (TC+CC)GenderMale291/174474/367183/204657/5711.001.224/0.117\
(0.951--1.575)1.854/\<0.001\
(1.379--2.493)1.397/0.006\
(1.102--1.772)0.615/\<0.001\
(0.480--0.786)Female94/79181/13687/65268/2011.000.888/0.538\
(0.610--1.295)0.881/0.576\
(0.566--1.373)0.886/0.503\
(0.622--1.262)1.052/0.790\
(0.725--1.525)Age\<63200/126295/228137/112432/3401.001.285/0.106\
(0.948--1.742)1.384/0.077\
(0.965--1.984)1.316/0.059\
(0.990--1.750)0.845/0.279\
(0.623--1.147)≥63185/127360/275133/157493/4321.000.980/0.893\
(0.734--1.309)1.572/0.009\
(1.121--2.204)1.140/0.347\
(0.868--1.497)0.628/0.001\
(0.476--0.829)Smoking statusNever282/149472/278206/147678/4251.001.109/0.417\
(0.863--1.426)1.357/0.042\
(1.012--1.821)1.184/0.159\
(0.936--1.499)0.787/0.057\
(0.616--1.007)Ever103/104183/22564/122247/3471.001.088/0.661\
(0.746--1.586)1.816/0.010\
(1.154--2.858)1.272/0.185\
(0.891--1.817)0.582/0.005\
(0.399--0.850)Alcohol consumptionNever358/183606/335253/185859/5201.001.070/0.555\
(0.855--1.339)1.415/0.009\
(1.089--1.839)1.172/0.140\
(0.949--1.446)0.738/0.007\
(0.593--0.919)Ever27/7049/16817/8466/2521.001.291/0.378\
(0.732--2.276)1.858/0.083\
(0.922--3.741)1.441/0.184\
(0.840--2.471)0.640/0.138\
(0.355--1.154) Table 6Stratified Analyses Between Rs8031440 Polymorphism and ESCC Risk by Gender, Age, Smoking Status, and Alcohol ConsumptionVariablesControl/CaseAdjusted OR/*P*\
(95% CI of OR)GGGAAAGA+AAGGGAAAGA+AAAA vs (GG+GA)GenderMale283/172474/364190/209664/5731.001.200/0.160\
(0.931--1.546)1.805/\<0.001\
(1.343--2.425)1.371/0.010\
(1.080--1.740)0.624/\<0.001\
(0.489--0.796)Female94/78182/13586/67268/2021.000.886/0.530\
(0.607--1.292)0.933/0.757\
(0.599--1.451)0.901/0.565\
(0.632--1.285)0.992/0.966\
(0.685--1.436)Age\<63194/125299/228139/113438/3411.001.238/0.170\
(0.913--1.680)1.353/0.100\
(0.944--1.941)1.274/0.097\
(0.957--1.697)0.845/0.278\
(0.624--1.145)≥63183/125357/271137/163494/4341.000.984/0.916\
(0.736--1.317)1.600/0.006\
(1.143--2.240)1.154/0.304\
(0.878--1.518)0.619/0.001\
(0.470--0.814)Smoking statusNever277/146473/276210/152683/4281.001.103/0.445\
(0.857--1.421)1.383/0.030\
(1.032--1.854)1.189/0.152\
(0.938--1.507)0.770/0.036\
(0.604--0.983)Ever100/104183/22366/124249/3471.001.055/0.782\
(0.723--1.540)1.742/0.016\
(1.109--2.739)1.232/0.253\
(0.861--1.762)0.595/0.007\
(0.409--0.866)Alcohol consumptionNever351/180607/333258/190865/5231.001.061/0.607\
(0.847--1.329)1.427/0.008\
(1.099--1.854)1.170/0.145\
(0.947--1.445)0.728/0.004\
(0.586--0.905)Ever26/7049/16618/8667/2521.001.236/0.467\
(0.698--2.186)1.757/0.112\
(0.877--3.519)1.378/0.247\
(0.801--2.371)0.658/0.156\
(0.369--1.174) Table 7Stratified Analyses Between Rs8031627 Polymorphism and ESCC Risk by Gender, Age, Smoking Status, and Alcohol ConsumptionVariablesControl/CaseAdjusted OR/*P*\
(95% CI of OR)GGGAAAGA+AAGGGAAAGA+AAAA vs (GG+GA)GenderMale292/173471/366185/206656/5721.001.244/0.090\
(0.967--1.602)1.876/\<0.001\
(1.396--2.522)1.421/0.004\
(1.120--1.801)0.614/\<0.001\
(0.480--0.785)Female95/79182/13685/65267/2011.000.895/0.562\
(0.614--1.303)0.912/0.686\
(0.585--1.422)0.900/0.561\
(0.632--1.282)1.021/0.915\
(0.703--1.482)Age\<63198/125297/229137/112434/3411.001.290/0.101\
(0.951--1.749)1.391/0.074\
(0.969--1.996)1.321/0.056\
(0.993--1.759)0.843/0.274\
(0.622--1.145)≥63189/127356/273133/159489/4321.001.003/0.982\
(0.752--1.339)1.628/0.005\
(1.162--2.279)1.173/0.251\
(0.894--1.539)0.616/0.001\
(0.467--0.813)Smoking statusNever282/148472/278206/148678/4261.001.121/0.372\
(0.872--1.441)1.385/0.030\
(1.032--1.858)1.201/0.128\
(0.948--1.520)0.777/0.044\
(0.608--0.993)Ever105/104181/22464/123245/3471.001.110/0.585\
(0.763--1.617)1.851/0.008\
(1.178--2.909)1.299/0.148\
(0.911--1.853)0.579/0.005\
(0.397--0.844)Alcohol consumptionNever360/182604/335253/186857/5211.001.089/0.458\
(0.870--1.362)1.446/0.006\
(1.113--1.879)1.194/0.098\
(0.968--1.474)0.730/0.005\
(0.586--0.908)Ever27/7049/16717/8566/2521.001.284/0.388\
(0.728--2.263)1.879/0.077\
(0.933--3.783)1.441/0.184\
(0.840--2.471)0.630/0.125\
(0.350--1.136)

Linkage Disequilibrium Analyses and Association Test {#s0003-s2004}
----------------------------------------------------

Linkage disequilibrium analyses of both the control and case groups are set out in [[supplementary Tables 1 and 2](https://www.dovepress.com/get_supplementary_file.php?f=250076.docx)]{.ul}. There were significant correlations between *SMAD3* rs3743342 C\>T, rs8025774 C\>T, rs8031440 G\>A and rs8031627 G\>A and risk of ESCC.

Haplotype Analysis of Polymorphisms and Susceptibility to ESCC {#s0003-s2005}
--------------------------------------------------------------

As summarized in [Table 8](#t0008){ref-type="table"}, haplotype analysis of 7 SNPs showed that *SMAD3*A~rs8028147~C~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*G~rs3463453~ (OR=0.809, 95% CI=0.674--0.972, *P*=0.023) and *SMAD3* A~rs8028147~G~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*A~rs3463453~ (OR=0.569, 95% CI=0.395--0.820, *P*=0.002) were associated with less susceptibility to ESCC, while *SMAD3*A~rs8028147~T~rs3743343~T~rs3743342~T~rs8025774~A~r8031440~A~rs8031627~*SMAD6*A~rs3463453~ was associated with higher risk of ESCC (OR = 1.318, 95% CI=1.056--1.645, P= 0.014).Table 8Haplotype Frequencies in the Case and Control Group, and Risk of ESCCHaplotypesCase (%)Control (%)OR (95% CI)*PSMAD3* A~rs8028147~C~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~ *SMAD6*A~rs3463453~4.34.01.075 (0.801--1.443)0.629*SMAD3* A~rs8028147~C~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*G~rs3463453~10.812.90.809 (0.674--0.972)0.023*SMAD3* A~rs8028147~G~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*A~rs3463453~2.23.70.569 (0.395--0.820)0.002*SMAD3* A~rs8028147~G~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*G~rs3463453~8.99.60.912 (0.744--1.117)0.373*SMAD3* A~rs8028147~T~rs3743343~T~rs3743342~T~rs8025774~A~r8031440~A~rs8031627~*SMAD6*A~rs3463453~8.66.71.318 (1.056--1.645)0.014*SMAD3* A~rs8028147~T~rs3743343~T~rs3743342~T~rs8025774~A~rs8031440~A~rs8031627~*SMAD6*G~rs3463453~23.921.41.148 (0.997--1.321)0.055*SMAD3* G~rs8028147~C~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*A~rs3463453~3.34.10.779 (0.568--1.067)0.119*SMAD3* G~rs8028147~C~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*G~rs3463453~11.310.41.100 (0.911--1.328)0.323*SMAD3* G~rs8028147~T~rs3743343~C~rs3743342~C~rs8025774~G~rs8031440~G~rs8031627~*SMAD6*G~rs3463453~5.96.70.872 (0.684--1.111)0.267*SMAD3* G~rs8028147~T~rs3743343~T~rs3743342~T~rs8025774~A~rs8031440~A~rs8031627~*SMAD6*A~rs3463453~4.94.41.117 (0.846--1.476)0.434*SMAD3* G~rs8028147~T~rs3743343~T~rs3743342~T~rs8025774~A~rs8031440~A~rs8031627~*SMAD6*G~rs3463453~13.112.91.018 (0.855--1.213)0.838

Discussion {#s0004}
==========

Herein, the association between *SMAD3/SMAD6* SNPs and the risk of ESCC among the Chinese population was assessed. Preliminary analysis revealed that the distributions of the 7 SNPs were consistent with that of HapMap data. As such, the results of our study could be generalized and used for the entire Chinese Han population.

Several studies postulate that SMAD3 plays a protective role in ESCC. Our study showed that the association between SMAD3 rs3743342 C\>T, rs8025774 C\>T, rs8031440 G\>A, rs8031627 G\>A, and ESCC was consistent in different genetic models. Thus, selected *SMAD3* SNPs may affect the susceptibility of the participants to ESCC in a positive correlated manner. However, mutant heterozygote of the mentioned 4 SNPs seemed to have no significant association with risk of ESCC compared with the wild genotype in the co-dominant model, which may be due to the inheritance mode and mechanism of SNPs on tumor development and progression.

Stratification analyses of the four SNPs further revealed that their effects varied in different subgroups. The SNPs significantly increased the risk of ESCC in males and participants aged more than 63 years. Smokers with *SMAD*3 rs3743342 C\>T, rs8025774 C\>T, or rs8031627 G\>A were more susceptible to ESCC while those with the rs8031440 wild-type homozygotes had a lower risk of ESCC than those with other genotypes. These results were consistent with previous results that showed ESCC is more prevalent in Chinese males than females, and in elder people than younger people, and smoking increases the risk of ESCC by about 3--7-fold.[@cit0015],[@cit0016] Cognizant to this, these results suggested that there exists an interaction between the environmental and genetic risk factors in tumorigenesis of ESCC. Non-alcohol drinking participants with *SMAD3* rs3743342 C\>T, rs8025774 C\>T, rs8031440, or rs8031627 G\>A were more susceptible to ESCC. However, there was no such correlation in the alcohol-drinking subgroup. The result seemed contradictory to the evidence that alcohol drinking is a significant contributory factor to the development of ESCC.[@cit0017] Thus, the mechanism underlying this discrepancy should be further investigated.

There was a significant correlation between rs3743342, rs8025774, rs8031440, and rs8031627 that further confirmed their similarities. The four SNPs were all located in the three-prime untranslated region (3ʹ-utr) of *SMAD3*. Many recent studies have reported that the 3ʹ-utr of *SMAD3* has an important impact on the development of various malignant tumors. For example, inhibition of micro-RNAs that target at the 3ʹ-utr of *SMAD3* leads to the upregulation of *SMAD3*, thereby constraining the epithelial--mesenchymal transition and invasion of non-small cell lung cancer.[@cit0018] In the same line, silencing the micro-RNAs that target the 3ʹ-utr of *SMAD3* decreases the expression of *SMAD3*, thereby inhibiting the proliferation of glioblastoma cells.[@cit0019] Based on these reports, it appears that these SNPs influence the risk of ESCC through post-transcriptional regulation. Raine et al reported that rs8031440 and rs3743342 were also correlated with primary osteoarthritis, aneurysms, and osteoarthritis syndrome.[@cit0020] It can be reasonably assumed that these SNPs affect the susceptibility to ESCC as well as that to other diseases.

The major limitation of our study was the lack of technical support to establish a single nucleotide mutation cell or animal model. As such, the biological function of these SNPs requires further research. In addition, our study was conducted in a single center, although the sample size was impressive.

Conclusion {#s0005}
==========

*SMAD3* rs3743342 C\>T, rs8025774 C\>T and rs8031627 G\>A increase the susceptibility of individuals to ESCC, particularly in males, people aged over 63 years, smokers, and non-alcohol drinking people. The distribution of the 7 SNPs was consistent with that of HapMap data based on their primary data. As such, the results of this study can be generalized and used as a useful resource for ESCC screening of the entire Chinse Han population.
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